17. Doxiadis, G.G., de Groot, N., Otting, N., de Vos-Rouweler, A.J., Bolijn, M.J.,
Heijmans, C.M., de Groot, N.G., van der Wiel, M.K., Remarque, E.J., Vangenot, C.,
et al. (2013). Haplotype diversity generated by ancient recombination-like events
in the MHC of Indian rhesus macaques. Immunogenetics 65, 569–584.
1. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and
Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872.
18. Hansen, S.G., Wu, H.L., Burwitz, B.J., Hughes, C.M., Hammond, K.B., Ventura, A.B.,
Reed, J.S., Gilbride, R.M., Ainslie, E., Morrow, D.W., et al. (2016). Broadly targeted
CD8+ T cell responses restricted by major histocompatibility complex E. Science
351, 714–720.
2. Nishimura, T., Kaneko, S., Kawana-Tachikawa, A., Tajima, Y., Goto, H., Zhu, D.,
Nakayama-Hosoya, K., Iriguchi, S., Uemura, Y., Shimizu, T., et al. (2013).
Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency
and redifferentiation. Cell Stem Cell 12, 114–126.
19. Liu, H., Zhu, F., Yong, J., Zhang, P., Hou, P., Li, H., Jiang, W., Cai, J., Liu, M., Cui, K.,
et al. (2008). Generation of induced pluripotent stem cells from adult rhesus monkey
fibroblasts. Cell Stem Cell 3, 587–590.
3. Vizcardo, R., Masuda, K., Yamada, D., Ikawa, T., Shimizu, K., Fujii, S., Koseki, H., and
Kawamoto, H. (2013). Regeneration of human tumor antigen-specific T cells from
iPSCs derived from mature CD8+ T cells. Cell Stem Cell 12, 31–36.
4. Ando, M., Nishimura, T., Yamazaki, S., Yamaguchi, T., Kawana-Tachikawa, A.,
Hayama, T., Nakauchi, Y., Ando, J., Ota, Y., Takahashi, S., et al. (2015). A safeguard
system for induced pluripotent stem cell-derived rejuvenated T cell therapy. Stem
Cell Reports 5, 597–608.
5. Higaki, K., Hirao, M., Kawana-Tachikawa, A., Iriguchi, S., Kumagai, A., Ueda, N., Bo,
W., Kamibayashi, S., Watanabe, A., Nakauchi, H., et al. (2018). Generation of HIVresistant macrophages from IPSCs by using transcriptional gene silencing and promoter-targeted RNA. Mol. Ther. Nucleic Acids 12, 793–804.
6. Xu, H., Wang, B., Ono, M., Kagita, A., Fujii, K., Sasakawa, N., Ueda, T., Gee, P.,
Nishikawa, M., Nomura, M., et al. (2019). Targeted disruption of HLA genes via
CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem
Cell 24, 566–578.e7.
7. Minagawa, A., Yoshikawa, T., Yasukawa, M., Hotta, A., Kunitomo, M., Iriguchi, S.,
Takiguchi, M., Kassai, Y., Imai, E., Yasui, Y., et al. (2018). Enhancing T cell receptor
stability in rejuvenated iPSC-derived T cells improves their use in cancer immunotherapy. Cell Stem Cell 23, 850–858.e4.
8. Kang, H., Minder, P., Park, M.A., Mesquitta, W.T., Torbett, B.E., and Slukvin, I.I.
(2015). CCR5 disruption in induced pluripotent stem cells using CRISPR/Cas9 provides selective resistance of immune cells to CCR5-tropic HIV-1 virus. Mol. Ther.
Nucleic Acids 4, e268.
9. Kamao, H., Mandai, M., Okamoto, S., Sakai, N., Suga, A., Sugita, S., Kiryu, J., and
Takahashi, M. (2014). Characterization of human induced pluripotent stem cellderived retinal pigment epithelium cell sheets aiming for clinical application. Stem
Cell Reports 2, 205–218.
10. Hallett, P.J., Deleidi, M., Astradsson, A., Smith, G.A., Cooper, O., Osborn, T.M.,
Sundberg, M., Moore, M.A., Perez-Torres, E., Brownell, A.L., et al. (2015).
Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson’s disease. Cell Stem Cell
16, 269–274.
11. Lin, Y., Liu, H., Klein, M., Ostrominski, J., Hong, S.G., Yada, R.C., Chen, G.,
Navarengom, K., Schwartzbeck, R., San, H., et al. (2018). Efficient differentiation of
cardiomyocytes and generation of calcium-sensor reporter lines from nonhuman primate iPSCs. Sci. Rep. 8, 5907.
20. Stremlau, M., Owens, C.M., Perron, M.J., Kiessling, M., Autissier, P., and Sodroski, J.
(2004). The cytoplasmic body component TRIM5a restricts HIV-1 infection in Old
World monkeys. Nature 427, 848–853.
21. Nakayama, E.E., Miyoshi, H., Nagai, Y., and Shioda, T. (2005). A specific region of 37
amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5a
determines species-specific restriction of simian immunodeficiency virus SIVmac
infection. J. Virol. 79, 8870–8877.
22. Ganser-Pornillos, B.K., and Pornillos, O. (2019). Restriction of HIV-1 and other retroviruses by TRIM5. Nat. Rev. Microbiol. 17, 546–556.
23. Wang, X., Yu, Q., Yuan, Y., Teng, Z., Li, D., and Zeng, Y. (2017). Targeting the rhesus
macaque TRIM5a gene to enhance the susceptibility of CD4+ T cells to HIV-1 infection. Arch. Virol. 162, 793–798.
24. Hütter, G., Nowak, D., Mossner, M., Ganepola, S., Müssig, A., Allers, K., Schneider,
T., Hofmann, J., Kücherer, C., Blau, O., et al. (2009). Long-term control of HIV by
CCR5 delta32/delta32 stem-cell transplantation. N. Engl. J. Med. 360, 692–698.
25. Gupta, R.K., Abdul-Jawad, S., McCoy, L.E., Mok, H.P., Peppa, D., Salgado, M.,
Martinez-Picado, J., Nijhuis, M., Wensing, A.M.J., Lee, H., et al. (2019). HIV-1 remission following CCR5D32/D32 haematopoietic stem-cell transplantation. Nature 568,
244–248.
26. Riolobos, L., Hirata, R.K., Turtle, C.J., Wang, P.-R., Gornalusse, G.G., Zavajlevski, M.,
Riddell, S.R., and Russell, D.W. (2013). HLA engineering of human pluripotent stem
cells. Mol. Ther. 21, 1232–1241.
27. Fang, R., Liu, K., Zhao, Y., Li, H., Zhu, D., Du, Y., Xiang, C., Li, X., Liu, H., Miao, Z.,
et al. (2014). Generation of naive induced pluripotent stem cells from rhesus monkey
fibroblasts. Cell Stem Cell 15, 488–497.
28. D’Souza, S.S., Maufort, J., Kumar, A., Zhang, J., Smuga-Otto, K., Thomson, J.A., and
Slukvin, I.I. (2016). GSK3b inhibition promotes efficient myeloid and lymphoid hematopoiesis from non-human primate-induced pluripotent stem cells. Stem Cell
Reports 6, 243–256.
29. Hong, S.G., Yada, R.C., Choi, K., Carpentier, A., Liang, T.J., Merling, R.K., Sweeney,
C.L., Malech, H.L., Jung, M., Corat, M.A.F., et al. (2017). Rhesus iPSC safe harbor
gene-editing platform for stable expression of transgenes in differentiated cells of
all germ layers. Mol. Ther. 25, 44–53.
30. Nishimura, K., Sano, M., Ohtaka, M., Furuta, B., Umemura, Y., Nakajima, Y., Ikehara,
Y., Kobayashi, T., Segawa, H., Takayasu, S., et al. (2011). Development of defective
and persistent Sendai virus vector: A unique gene delivery/expression system ideal
for cell reprogramming. J. Biol. Chem. 286, 4760–4771.
12. Hong, S.G., Winkler, T., Wu, C., Guo, V., Pittaluga, S., Nicolae, A., Donahue, R.E.,
Metzger, M.E., Price, S.D., Uchida, N., et al. (2014). Path to the clinic: Assessment
of iPSC-based cell therapies in vivo in a nonhuman primate model. Cell Rep. 7,
1298–1309.
31. Ying, Q.-L., Wray, J., Nicholas, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen,
P., and Smith, A. (2008). The ground state of embryonic stem cell self-renewal.
Nature 453, 519–523.
13. Shiba, Y., Gomibuchi, T., Seto, T., Wada, Y., Ichimura, H., Tanaka, Y., Ogasawara, T.,
Okada, K., Shiba, N., Sakamoto, K., et al. (2016). Allogeneic transplantation of iPS
cell-derived cardiomyocytes regenerates primate hearts. Nature 538, 388–391.
32. Lengerke, C., Schmitt, S., Bowman, T.V., Jang, I.H., Maouche-Chretien, L.,
McKinney-Freeman, S., Davidson, A.J., Hammerschmidt, M., Rentzsch, F., Green,
J.B.A., et al. (2008). BMP and Wnt specify hematopoietic fate by activation of the
Cdx-Hox pathway. Cell Stem Cell 2, 72–82.
14. Hong, S.G., Lin, Y., Dunbar, C.E., and Zou, J. (2016). The role of nonhuman primate
animal models in the clinical development of pluripotent stem cell therapies. Mol.
Ther. 24, 1165–1169.
15. Estes, J.D., Wong, S.W., and Brenchley, J.M. (2018). Nonhuman primate models of
human viral infections. Nat. Rev. Immunol. 18, 390–404.
16. de Groot, N., Doxiadis, G.G., Otting, N., de Vos-Rouweler, A.J., and Bontrop, R.E.
(2014). Differential recombination dynamics within the MHC of macaque species.
Immunogenetics 66, 535–544.
272
33. Woods, N.B., Parker, A.S., Moraghebi, R., Lutz, M.K., Firth, A.L., Brennand, K.J.,
Berggren, W.T., Raya, A., Izpisúa Belmonte, J.C., Gage, F.H., and Verma, I.M.
(2011). Brief report: Efficient generation of hematopoietic precursors and progenitors
from human pluripotent stem cell lines. Stem Cells 29, 1158–1164.
34. Gori, J.L., Chandrasekaran, D., Kowalski, J.P., Adair, J.E., Beard, B.C., D’Souza, S.L.,
and Kiem, H.-P. (2012). Efficient generation, purification, and expansion of CD34+
hematopoietic progenitor cells from nonhuman primate-induced pluripotent stem
cells. Blood 120, e35–e44.
Molecular Therapy: Methods & Clinical Development Vol. 21 June 2021
A Self-archived copy in
Kyoto University Research Information Repository
https://repository.kulib.kyoto-u.ac.jp
www.moleculartherapy.org
35. Garneau, N.L., Wilusz, J., and Wilusz, C.J. (2007). The highways and byways of
mRNA decay. Nat. Rev. Mol. Cell Biol. 8, 113–126.
36. Lykke-Andersen, S., and Jensen, T.H. (2015). Nonsense-mediated mRNA decay: An
intricate machinery that shapes transcriptomes. Nat. Rev. Mol. Cell Biol. 16, 665–677.
39. Abed, S., Tubsuwan, A., Chaichompoo, P., Park, I.H., Pailleret, A., Benyoucef, A.,
Tosca, L., De Dreuzy, E., Paulard, A., Granger-Locatelli, M., et al. (2015).
Transplantation of Macaca cynomolgus iPS-derived hematopoietic cells in NSG
immunodeficient mice. Haematologica 100, e428–e431.
37. Portilho, D.M., Fernandez, J., Ringeard, M., Machado, A.K., Boulay, A., Mayer, M.,
Müller-Trutwin, M., Beignon, A.S., Kirchhoff, F., Nisole, S., and Arhel, N.J. (2016).
Endogenous TRIM5a function is regulated by SUMOylation and nuclear sequestration for efficient innate sensing in dendritic cells. Cell Rep. 14, 355–369.
40. Katayama, M., Hirayama, T., Horie, K., Kiyono, T., Donai, K., Takeda, S., Nishimori,
K., and Fukuda, T. (2016). Induced pluripotent stem cells with six reprogramming
factors from prairie vole, which is an animal model for social behaviors. Cell
Transplant. 25, 783–796.
38. Taya, K., Nakayama, E.E., and Shioda, T. (2014). Moderate restriction of macrophage-tropic human immunodeficiency virus type 1 by SAMHD1 in monocytederived macrophages. PLoS ONE 9, e90969.
41. Katayama, M., Hirayama, T., Tani, T., Nishimori, K., Onuma, M., and Fukuda, T.
(2018). Chick derived induced pluripotent stem cells by the poly-cistronic transposon
with enhanced transcriptional activity. J. Cell. Physiol. 233, 990–1004.
Molecular Therapy: Methods & Clinical Development Vol. 21 June 2021
273
...
論文の公開元へ
